GABRIELLA DAVIS: Open Payments
NPI 1366848541 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 3 payments from 3 companies in 2025. Trend: 2023 $186 · 2024 $147 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $105 |
| Verona Pharma, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Xeomin, Ohtuvayre, OFEV.
Industry payments across TX — which companies pay providers there.
